Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mazen Noureddin

Showing results (1-10 of 338) with videos related to

Pageof 34
Sort By:
Gastroenterology & Hepatology|April 25, 2022
Magnetic Resonance Elastography as a Predictor of Response to Therapy in Patients With Nonalcoholic SteatohepatitisMazen Noureddin
Gastroenterology & Hepatology|February 2, 2026
Overview of Metabolic Dysfunction-Associated Steatohepatitis CirrhosisMazen Noureddin
Hepatology (Baltimore, Md.)|February 27, 2021
Artificial Intelligence in NASH Histology: Human Teaches a Machine for the Machine to Help HumansMazen Noureddin
Gastroenterology & Hepatology|September 29, 2023
Utilization of Noninvasive Tests to Diagnose At-Risk Metabolic Dysfunction-Associated SteatohepatitisMazen Noureddin
Gastroenterology & Hepatology|May 26, 2021
Current Understanding of Risk for Nonalcoholic Steatohepatitis and Progressive FibrosisMazen Noureddin
Hepatology (Baltimore, Md.)|March 19, 2024
MASH clinical trials and drugs pipeline: An impending tsunamiMazen Noureddin
Frontiers in Endocrinology|December 20, 2021
Current and Potential Therapies Targeting Inflammation in NASHSomaya Albhaisi, Mazen Noureddin
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 1, 2024
ReplyMadeleine Chang, Mazen Noureddin
Clinics in Liver Disease|April 29, 2022
The Interplay Between Nonalcoholic Fatty Liver Disease and Kidney DiseaseEmily Truong, Mazen Noureddin
Current Gastroenterology Reports|December 3, 2013
Hepatitis delta: epidemiology, diagnosis and management 36 years after discoveryMazen Noureddin, Robert Gish
Pageof 34

Showing results (1-10 of 338) with videos related to

Sort By:
Pageof 34
Gastroenterology & Hepatology|April 25, 2022
Magnetic Resonance Elastography as a Predictor of Response to Therapy in Patients With Nonalcoholic SteatohepatitisMazen Noureddin
Gastroenterology & Hepatology|February 2, 2026
Overview of Metabolic Dysfunction-Associated Steatohepatitis CirrhosisMazen Noureddin
Hepatology (Baltimore, Md.)|February 27, 2021
Artificial Intelligence in NASH Histology: Human Teaches a Machine for the Machine to Help HumansMazen Noureddin
Gastroenterology & Hepatology|September 29, 2023
Utilization of Noninvasive Tests to Diagnose At-Risk Metabolic Dysfunction-Associated SteatohepatitisMazen Noureddin
Gastroenterology & Hepatology|May 26, 2021
Current Understanding of Risk for Nonalcoholic Steatohepatitis and Progressive FibrosisMazen Noureddin
Hepatology (Baltimore, Md.)|March 19, 2024
MASH clinical trials and drugs pipeline: An impending tsunamiMazen Noureddin
Frontiers in Endocrinology|December 20, 2021
Current and Potential Therapies Targeting Inflammation in NASHSomaya Albhaisi, Mazen Noureddin
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 1, 2024
ReplyMadeleine Chang, Mazen Noureddin
Clinics in Liver Disease|April 29, 2022
The Interplay Between Nonalcoholic Fatty Liver Disease and Kidney DiseaseEmily Truong, Mazen Noureddin
Current Gastroenterology Reports|December 3, 2013
Hepatitis delta: epidemiology, diagnosis and management 36 years after discoveryMazen Noureddin, Robert Gish
Pageof 34